GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Scienture Holdings Inc (NAS:SCNX) » Definitions » Days Sales Outstanding

SCNX (Scienture Holdings) Days Sales Outstanding : 18.08 (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Scienture Holdings Days Sales Outstanding?

Scienture Holdings's average Accounts Receivable for the three months ended in Dec. 2024 was $0.01 Mil. Scienture Holdings's Revenue for the three months ended in Dec. 2024 was $0.05 Mil. Hence, Scienture Holdings's Days Sales Outstanding for the three months ended in Dec. 2024 was 18.08.

The historical rank and industry rank for Scienture Holdings's Days Sales Outstanding or its related term are showing as below:

SCNX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.02   Med: 34.39   Max: 168.59
Current: 27.31

During the past 13 years, Scienture Holdings's highest Days Sales Outstanding was 168.59. The lowest was 17.02. And the median was 34.39.

SCNX's Days Sales Outstanding is ranked better than
73.44% of 659 companies
in the Healthcare Providers & Services industry
Industry Median: 47.87 vs SCNX: 27.31

Scienture Holdings's Days Sales Outstanding declined from Dec. 2023 (601.26) to Dec. 2024 (18.08).


Scienture Holdings Days Sales Outstanding Historical Data

The historical data trend for Scienture Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scienture Holdings Days Sales Outstanding Chart

Scienture Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.02 32.92 28.65 168.59 29.31

Scienture Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 601.26 - 48.03 16.14 18.08

Competitive Comparison of Scienture Holdings's Days Sales Outstanding

For the Pharmaceutical Retailers subindustry, Scienture Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's Days Sales Outstanding falls into.


;
;

Scienture Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Scienture Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (0 + 0.011) / 1 ) / 0.137*365
=0.011 / 0.137*365
=29.31

Scienture Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (0.01 + 0.011) / 2 ) / 0.053*365 / 4
=0.0105 / 0.053*365 / 4
=18.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scienture Holdings  (NAS:SCNX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Scienture Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Scienture Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Scienture Holdings Business Description

Traded in Other Exchanges
Address
6308 Benjamin Road, Suite 708, Tampa, FL, USA, 33634
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Executives
A. Jeffrey Newell director 645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell director 17537 DARBY LANE, LUTZ FL 33558
Janet Huffman officer: CFO, PAO, PFO 5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson director 17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings director 3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel director, 10 percent owner, officer: President 17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts director PO BOX 15012, SARASOTA FL 34277
Gary Augusta director 700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss officer: CFO 17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu director, 10 percent owner, officer: CEO 8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida director 1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope director 4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu 10 percent owner 17537 DARBY LANE, LUTZ FL 33558